Make Kitco Your Homepage

EU regulators to probe Johnson & Johnson's Takeda deal

Kitco News

BRUSSELS (Reuters) - EU antitrust regulators opened on Wednesday a full-scale investigation into Johnson & Johnson’s (JNJ.N) buy of Takeda Pharmaceutical Co’s (4502.T) surgical patch product TachoSil, saying the deal may hurt competition and innovation.

The European Commission set an Aug. 10 deadline for its decision on the deal.

Japan’s biggest drugmaker announced the disposal of $10 billion worth of assets to cut debt in May last year, and also said it was selling TachoSil, a surgical patch for bleeding control, to Johnson & Johnson’s Ethicon for $400 million.

Reporting by Foo Yun Chee

Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.